Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV)’s share price traded up 5.8% during mid-day trading on Wednesday . The stock traded as high as $2.94 and last traded at $2.93, with a volume of 103,333 shares trading hands. The stock had previously closed at $2.77.

Several equities analysts have issued reports on the company. Rodman & Renshaw reiterated a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research note on Saturday, May 14th. Zacks Investment Research upgraded Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $6.25 target price on the stock in a research note on Wednesday, April 27th.

The stock’s 50-day moving average is $3.54 and its 200-day moving average is $3.95. The company’s market cap is $11.55 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.